Gough DB, Donohue JH, Schutt AJ, et al. Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach. Ann Surg. 1994;219:112–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sugarbaker PH. New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol. 2006;7:69–76.

Article  PubMed  Google Scholar 

Moran BJ, Cecil TD. The etiology, clinical presentation, and management of pseudomyxoma peritonei. Surg Oncol Clin N Am. 2003;12:585–603.

Article  PubMed  Google Scholar 

Kataoka A, Ito K, Takemura N, et al. Immunohistochemical staining as supportive diagnostic tool for pseudomyxoma peritonei arising from intraductal papillary mucinous neoplasm: a report of two cases and literature review. Pancreatology. 2020;20:1226–33.

Article  CAS  PubMed  Google Scholar 

Ansari N, Chandrakumaran K, Dayal S, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1000 patients with perforated appendiceal epithelial tumours. Eur J Surg Oncol. 2016;42:1035–41.

Article  CAS  PubMed  Google Scholar 

Chua TC, Moran BJ, Sugarbaker PH, et al. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol. 2012;30:2449–56.

Article  PubMed  Google Scholar 

Fung X, Li IC, Chandrakumaran K, et al. Early postoperative intraperitoneal chemotherapy (EPIC) following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in 632 patients with pseudomyxoma peritonei of appendiceal origin: a single institution experience. Eur J Surg Oncol. 2022;48:1614–8.

Article  PubMed  Google Scholar 

Youssef H, Newman C, Chandrakumaran K, et al. Operative findings, early complications, and long-term survival in 456 patients with pseudomyxoma peritonei syndrome of appendiceal origin. Dis Colon Rectum. 2011;54:293–9.

Article  PubMed  Google Scholar 

Sugarbaker PH. Technical handbook for the integration of cytoreductive surgery and perioperative intraperitoneal chemotherapy into the surgical managements of gastrointestinal and gynecologic malignancy. 4th ed. Michigan: The Ludann Company Grand Rapids; 2005.

Google Scholar 

Mittal R, Chandramohan A, Moran B. Pseudomyxoma peritonei: natural history and treatment. Int J Hyperth. 2017;33:511–9.

Article  Google Scholar 

Smeenk RM, van Velthuysen ML, Verwaal VJ, et al. Appendiceal neoplasms and pseudomyxoma peritonei: a population based study. Eur J Surg Oncol. 2008;34:196–201.

Article  CAS  PubMed  Google Scholar 

Han XD, Zhou N, Lu YY, et al. Pseudomyxoma peritonei originating from intestinal duplication: a case report and review of the literature. World J Clin Cases. 2021;9:7459–67.

Article  PubMed  PubMed Central  Google Scholar 

Zanelli M, Casadei R, Santini D, et al. Pseudomyxoma peritonei associated with intraductal papillary-mucinous neoplasm of the pancreas. Pancreas. 1998;17:100–2.

Article  CAS  PubMed  Google Scholar 

Jabłońska B. Pancreatic cysts: etiology, diagnosis and management. Cent Eur J Med. 2014;9:92–107.

Google Scholar 

Jabłońska B, Szmigiel P, Mrowiec S. Pancreatic intraductal papillary mucinous neoplasms: current diagnosis and management. World J Gastrointest Oncol. 2021;13:1880–95.

Article  PubMed  PubMed Central  Google Scholar 

Hirono S, Yamaue H. Surgical strategy for intraductal papillary mucinous neoplasms of the pancreas. Surg Today. 2020;50:50–5.

Article  CAS  PubMed  Google Scholar 

Tanaka M, Fernández-Del Castillo C, Kamisawa T, et al. Revisions of International Consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology. 2017;17:738–53.

Article  PubMed  Google Scholar 

Furukawa T, Kloppel G, Volkan Adsay N, et al. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch. 2005;447:794–9.

Article  PubMed  Google Scholar 

Imaoka H, Yamao K, Hijioka S, et al. Pseudomyxoma peritonei arising from intraductal papillary neoplasm after surgical pancreatectomy: report of 2 cases and review of the literature. Clin J Gastroenterol. 2012;5:15–9.

Article  PubMed  Google Scholar 

Sirisai C, Yonemura Y, Ishibashi H, et al. Hyperthermic intraperitoneal chemotherapy in management of malignant intraductal papillary mucinous neoplasm with peritoneal dissemination: case report. Int J Surg Case Rep. 2019;63:85–8.

Article  PubMed  PubMed Central  Google Scholar 

Imaoka H, Yamao K, Salem AA, et al. Pseudomyxoma peritonei caused by acute pancreatitis in intraductal papillary mucinous carcinoma of the pancreas. Pancreas. 2006;32:223–4.

Article  PubMed  Google Scholar 

Adsay NV, Merati K, Basturk O, et al. Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an “intestinal” pathway of carcinogenesis in the pancreas. Am J Surg Pathol. 2004;28:839–48.

Article  PubMed  Google Scholar 

Basturk O, Khayyata S, Klimstra DS, et al. Preferential expression of MUC6 in oncocytic and pancreatobiliary types of intraductal papillary neoplasms highlights a pyloropancreatic pathway, distinct from the intestinal pathway, in pancreatic carcinogenesis. Am J Surg Pathol. 2010;34:364–70.

Article  PubMed  PubMed Central  Google Scholar 

Delhorme JB, Severac F, Averous G, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendicular and extra-appendicular origin. Br J Surg. 2018;105:668–76.

Article  PubMed  Google Scholar 

Furukawa T, Klöppel G, Volkan Adsay N, et al. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch. 2005;447:794–9.

Article  PubMed  Google Scholar 

Kloek JJ, van der Gaag NA, Erdogan D, et al. A comparative study of intraductal papillary neoplasia of the biliary tract and pancreas. Hum Pathol. 2011;42:824–32.

Article  CAS  PubMed  Google Scholar 

Strickland S, Parra-Herran C. Immunohistochemical characterization of appendiceal mucinous neoplasms and the value of special AT-rich sequence-binding protein 2 in their distinction from primary ovarian mucinous tumours. Histopathology. 2016;68:977–87.

Article  PubMed  Google Scholar 

Arjona-Sanchez A, Munoz-Casares C, Ortega-Salas R, et al. Long-term survival with peritoneal mucinous carcinomatosis from intraductal mucinous papillary pancreatic carcinoma treated with complete cytoreduction and hyperthermic intraperitoneal chemotherapy. Int J Hyperth. 2014;30:408–11.

Article  CAS  Google Scholar 

Hackeng WM, de Guerre L, Kuypers KC, et al. Pseudomyxoma peritonei after a total pancreatectomy for intraductal papillary mucinous neoplasm with colloid carcinoma in lynch syndrome. Pancreas. 2019;48:135–8.

Article  PubMed  Google Scholar 

Yajima N, Wada R, Yamagishi S, et al. Immunohistochemical expressions of cytokeratins, mucin core proteins, p53, and neuroendocrine cell markers in epithelial neoplasm of appendix. Hum Pathol. 2005;36:1217–25.

Article  CAS  PubMed  Google Scholar 

Sugarbaker PH. Surgical treatment of peritoneal carcinomatosis: 1988 Du Pont lecture. Can J Surg. 1989;32:164–70.

CAS  PubMed  Google Scholar 

Rizvi SA, Syed W, Shergill R. Approach to pseudomyxoma peritonei. World J Gastrointest Surg. 2018;10:49–56.

Article  PubMed  PubMed Central  Google Scholar 

Sugarbaker PH. Pseudomyxoma peritonei. A cancer whose biology is characterized by a redistribution phenomenon. Ann Surg. 1994;219:109–11.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res. 1996;82:359–74.

Article  CAS  PubMed  Google Scholar 

Kim SI, Kim JW. Role of surgery and hyperthermic intraperitoneal chemotherapy in ovarian cancer. ESMO Open. 2021;6: 100149.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kusamura S, Barretta F, Yonemura Y, et al. The role of hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei after cytoreductive surgery. JAMA Surg. 2021;156: e206363.

Article  PubMed  PubMed Central  Google Scholar 

de Bree E. Optimal drugs for HIPEC in different tumors. J Buon. 2015;20(Suppl 1):S40–6.

PubMed  Google Scholar 

Saint-Lorant G, Rodier S, Guilloit JM, et al. Is the blood of a surgeon performing HIPEC contaminated by irinotecan, its major metabolites and platinum compounds? Pleura Peritoneum. 2021;6:49–55.

Article  PubMed  PubMed Central  Google Scholar 

McConnell YJ, Mack LA, Francis WP, et al. HIPEC + EPIC versus HIPEC-alone: differences in major complications following cytoreduction surgery for peritoneal malignancy. J Surg Oncol. 2013;107:591–6.

Article  CAS  PubMed  Google Scholar 

Tan GH, Ong WS, Chia CS, et al. Does early post-operative intraperitone